• Disrupting BRD4–RAC1–c-MYC–G9a Axis Suppresses Breast Tumori

  2026-05-14

  This study demonstrates that simultaneous inhibition of BRD4 and RAC1 suppresses breast cancer growth, stemness, and tumorigenesis by disrupting the c-MYC–G9a–FTH1 axis and downregulating HDAC1. The mechanistic insights illuminate new epigenetic targets for therapeutic intervention across major breast cancer subtypes.

• Reversine and High-Content Gastruloid Screening: A New Era i

  2026-05-13

  Discover how Reversine, a potent Aurora kinase inhibitor, is transforming advanced cancer and developmental biology research. This article uniquely connects high-content gastruloid screening with precise mitotic checkpoint modulation.

• Technical Guide: CDK9 Inhibitor (A3294) for Transcription Re

  2026-05-13

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for the precise study of transcription elongation and HIV-1 propagation inhibition, offering high specificity and minimal cytotoxicity. It is not suitable for broad-spectrum CDK inhibition or protocols requiring long-term storage of working solutions. Researchers should follow strict solubility and storage guidelines to ensure reproducibility.

• A 83-01: Selective ALK-5 Inhibitor for TGF-β Pathway Researc

  2026-05-12

  A 83-01 is a nanomolar-potency ALK-5 inhibitor that enables precise suppression of TGF-β/Smad signaling. This product dossier details its selectivity, validated benchmarks, and protocol parameters for organoid, EMT, and growth inhibition studies.

• Benzyl Quinolone Carboxylic Acid: Applied M1 Receptor Modula

  2026-05-12

  Benzyl Quinolone Carboxylic Acid (BQCA) empowers researchers to dissect M1 muscarinic acetylcholine receptor signaling with unprecedented selectivity and mechanistic control. This guide delivers advanced, evidence-backed workflows and troubleshooting for cognitive and Alzheimer’s disease research, integrating new insights from GRK signaling bias studies.

• HDAC Inhibition Suppresses NUT Carcinoma via Chromatin Remod

  2026-05-11

  Shiota et al. conducted a high-throughput chemical screen revealing that diverse histone deacetylase (HDAC) inhibitors repress NUT-mediated oncogenic transcription in NUT carcinoma. Their findings illuminate the role of chromatin acetylation dynamics in tumor pathogenesis and suggest HDAC inhibition as a mechanistically grounded therapeutic strategy.

• Ceapin-A7: Precision ER Stress Modulation for Translational

  2026-05-11

  This article dissects the mechanistic role and translational potential of Ceapin-A7—a selective ER stress blocker targeting the ATF6α pathway. Integrating recent findings on the PTX3–TLR4/NF-κB–FGF21 axis in osteonecrosis and scenario-driven guidance, it offers strategic direction for researchers aiming to leverage unfolded protein response modulation in disease modeling and therapeutic innovation.

• Dual Terminal Oxidase Inhibition by Pretomanid in TB Therapy

  2026-05-10

  This study identifies pretomanid’s simultaneous inhibition of both cytochrome bcc:aa3 and bd oxidases in Mycobacterium tuberculosis, defining a new paradigm in bactericidal regimen design. The findings reveal strong synergy between pretomanid and other respiratory inhibitors, suggesting rational combination strategies to combat drug-tolerant and drug-resistant tuberculosis.

• Applied Workflows with 10 mM dNTP Mixture for DNA Synthesis

  2026-05-09

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture empowers high-fidelity DNA synthesis, PCR, and advanced nanoparticle research with unparalleled stability and convenience. Discover optimized protocols, advanced troubleshooting, and the latest innovations for reproducible, efficient molecular biology workflows.

• 2X HyperFusion High-Fidelity Master Mix: Precision for Cloni

  2026-05-08

  Harness the power of 2X HyperFusion™ High-Fidelity Master Mix for high-accuracy DNA amplification and seamless blunt-end PCR product generation. Discover advanced workflows and troubleshooting strategies that accelerate cloning, CRISPR, and translational immunotherapy research.

• Berberine Hydrochloride Induces Tuft Cells to Prevent Bone L

  2026-05-08

  A recent study reveals that berberine hydrochloride mitigates estrogen deficiency-associated bone loss by expanding intestinal tuft cells through a butyrate-GPR41 signaling pathway. This mechanistic insight advances our understanding of the gut-bone axis, suggesting new approaches for postmenopausal osteoporosis and osteoimmune research.

• HotStart™ 2X Green qPCR Master Mix: Specificity & Real-Time

  2026-05-07

  HotStart™ 2X Green qPCR Master Mix enables high-sensitivity, SYBR Green-based real-time PCR with robust specificity and reproducibility. Antibody-mediated hot-start inhibition of Taq polymerase minimizes non-specific amplification, supporting precise nucleic acid quantification in gene expression studies.

• CP-673451: Selective PDGFRα/β Inhibitor for Tumor Models

  2026-05-07

  CP-673451 delivers exceptional selectivity for PDGFRα/β, enabling precise angiogenesis inhibition and tumor growth suppression in advanced xenograft models. Recent insights underscore its unique potency in ATRX-deficient glioma research, providing translational relevance for cancer biology workflows.

• Cimetidine: Advanced Histamine-2 Receptor Antagonist for Bar

  2026-05-06

  Cimetidine’s unique profile as a histamine-2 receptor antagonist and partial agonist empowers reproducible, high-throughput workflows in both gastrointestinal cancer and blood-brain barrier (BBB) research. Its superior solubility and validated purity, supplied by APExBIO, streamline experimental setup and troubleshooting for robust, data-driven outcomes.

• WNT5a/GSK3/β-Catenin Axis Controls FAP Adipogenesis in Muscl

  2026-05-06

  This study reveals that the WNT5a/GSK3/β-catenin signaling axis critically modulates adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). The findings highlight potential intervention points for limiting muscle fatty degeneration, with direct implications for myopathy research and the development of targeted Wnt signaling pathway inhibitors.

16216 records 1/1082 page Next 12345 下5页 Last page